66th Day Of Lockdown

Maharashtra59546186161982 Tamil Nadu1937210548148 Delhi162817495316 Gujarat155728003960 Rajasthan80674815180 Madhya Pradesh74534050321 Uttar Pradesh71704215197 West Bengal45361668295 Andhra Pradesh3245213359 Bihar3185105015 Karnataka253381847 Telangana2256134567 Punjab2158194640 Jammu and Kashmir203685927 Odisha16608877 Haryana150488119 Kerala10895558 Assam8801044 Uttarakhand493794 Jharkhand4621914 Chandigarh3641894 Chhatisgarh364830 Tripura2421650 Himachal Pradesh223634 Goa68370 Puducherry49170 Meghalaya20121 Nagaland1800 Manipur540 Arunachal Pradesh210 Mizoram110 Sikkim100
Science 01 Apr 2020 Anti-flu drug Avigan ...

Anti-flu drug Avigan being tested by Japan's Fujifilm to treat coronavirus

AFP
Published Apr 1, 2020, 2:37 pm IST
Updated Apr 1, 2020, 2:37 pm IST
Trials in China have suggested Avigan could play a role in shortening the recovery time for patients infected with coronavirus.
Avigan will be administered for a maximum of 14 days to coronavirus patients between the age of 20 and 74 who have mild pneumonia, Fujifilm said. (Representative Image)
 Avigan will be administered for a maximum of 14 days to coronavirus patients between the age of 20 and 74 who have mild pneumonia, Fujifilm said. (Representative Image)

Tokyo: Japan's Fujifilm has begun clinical trials to test the effectiveness of its anti-flu drug Avigan in treating patients with the new coronavirus, after reports of promising results in China.

Trials in China have suggested Avigan could play a role in shortening the recovery time for patients infected with coronavirus.

 

"The trial will be conducted on 100 patients until the end of June," a company spokesman told AFP on Wednesday.

"We will collect data, analyse them and file for approval after that," he added.

The drug will be administered for a maximum of 14 days to coronavirus patients between 20 and 74 years old with mild pneumonia, the spokesman said.

The study excludes pregnant women due to side effects shown in animal testing, he added.

The phase three trial comes after Prime Minister Shinzo Abe said Saturday that the government "will begin the necessary process to formally approve (Avigan) as a treatment against the new coronavirus." China has already completed clinical trials on favipiravir, the main ingredient in Avigan, the country's ministry of science and technology said last month.

Two trials in the country found the drug shortened recovery time for patients, but Fujifilm was not involved in those programmes.

Avigan is currently approved for manufacture and sale in Japan as an antiviral drug for flu.

"It is expected that Avigan may potentially have an antiviral effect on the new coronavirus" given the way it works on the flu virus, Fujifilm said in a statement announcing the trial.

Researchers and companies around the world are racing to find a cure for the new coronavirus, with the focus on existing medicines such as anti-malaria and anti-HIV drugs.

Hydroxychloroquine and chloroquine to treat malaria have shown early promise against the COVID-19 illness in early studies in France and China.

But experts urge caution until bigger trials demonstrate their effectiveness. The use of Hydroxychloroquine in particular has led to the death of a person in Assam, India, while three Nigerians overdosed on the drug hoping to prevent coronavirus infection.

Medical researchers around the world are also working to find a vaccine for the virus.

Click on Deccan Chronicle Technology and Science for the latest news and reviews. Follow us on Facebook, Twitter

...




ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT